Diet and Progression of CKD in Patients With Type 2 Diabetes Mellitus
The Association Between Dietary Pattern and the Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
1 other identifier
observational
160
0 countries
N/A
Brief Summary
The aim of this study is to investigate the relationship between dietary patterns and the progression of chronic kidney disease (CKD) in patients with type 2 diabetes mellitus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2025
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 22, 2025
CompletedFirst Posted
Study publicly available on registry
September 12, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
September 12, 2025
August 1, 2025
3 years
August 22, 2025
September 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of the influence of dietary pattern on the progression of chronic kidney disease among patients with type 2 Diabetes Milletus
Primary Outcomes Measures 1\. change in estimated glomerular filtration rate (eGFR) from baseline to 6 month using CKD-EPI formula mL/min/1.73 m² Time frame 6 month
6 month
Eligibility Criteria
Adults aged above 18 years with chronic kidney disease stages 1-4 and type 2 Diabetes Milletus
You may qualify if:
- Adults aged above 18 years
- Diagnosed with type 2 diabetes mellitus according to ADA criteria.
- Diagnosed with chronic kidney disease stages 1-4 (eGFR 15-90 mL/min/1.73 m²) for at least 3 months.
- Willing and able to provide informed consent
You may not qualify if:
- Patients with end-stage renal disease (CKD stage 5 or on dialysis).
- History of kidney transplantation.
- Acute kidney injury within the past 3 months.
- Pregnant or lactating women.
- Patients with severe comorbid conditions (e.g., active malignancy, severe heart failure).
- Use of medications known to significantly affect renal function (other than standard antihypertensive or antidiabetic therapy).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- resident physician ,internal medicine
Study Record Dates
First Submitted
August 22, 2025
First Posted
September 12, 2025
Study Start
October 1, 2025
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
September 12, 2025
Record last verified: 2025-08